Amonafide (originally AS1413) (INN trade name Quinamed) is a drug that is being studied in the treatment of cancer. It belongs to the families of drugs called topoisomerase inhibitors and DNA intercalators.It is being developed as an anti-cancer therapy by Antisoma.As of 2008 it is in Phase III clinical trials.e.g. In March 2010 it is Phase III trial against secondary acute myeloid leukaemia (AML).
This page contains content from the copyrighted Wikipedia article "Amonafide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
